IQVIA Quarterly Cash Flow Statement
NYSE: IQVHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
IQVIA free cash flow
In the quarter ended Mar 31, 2026, IQVIA generated $618.0 million of operating cash flow and spent $127.0 million on capital expenditures. That left free cash flow of $491.0 million, a free-cash-flow margin of 11.8% of revenue. Free cash flow was up 15.3% from the prior year's $426.0 million.
IQVIA returned $552.0 million to shareholders through share repurchases, equal to 112% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
IQVIA cash flow statement (quarterly)
| Quarter (USD) | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 275.00M | 514.00M | 332.00M | 266.00M | 249.00M | 437.00M | 285.00M | 363.00M | 288.00M | 469.00M | 303.00M | 297.00M |
| Net Income growth (YoY) | +10.44% | +17.62% | +16.49% | -26.72% | -13.54% | -6.82% | -5.94% | +22.22% | -0.35% | +106.61% | +4.84% | +16.02% |
| Depreciation & Amortization | 288.00M | 317.00M | 286.00M | 276.00M | 265.00M | 303.00M | 278.00M | 269.00M | 264.00M | 316.00M | 297.00M | 259.00M |
| Stock-Based Compensation | 65.00M | 60.00M | 55.00M | 60.00M | 72.00M | 48.00M | 54.00M | 48.00M | 56.00M | 45.00M | 47.00M | 50.00M |
| Change in Working Capital | 143.00M | -42.00M | 37.00M | 183.00M | 161.00M | -45.00M | 13.00M | -103.00M | 115.00M | -39.00M | -6.00M | 17.00M |
| Operating Cash Flow | 618.00M | 735.00M | 908.00M | 443.00M | 568.00M | 885.00M | 721.00M | 588.00M | 522.00M | 747.00M | 583.00M | 402.00M |
| Capital Expenditures | -127.00M | -174.00M | -136.00M | -151.00M | -142.00M | -164.00M | -150.00M | -143.00M | -145.00M | -179.00M | -146.00M | -160.00M |
| Investing Cash Flow | -196.00M | -1.10B | -550.00M | -346.00M | -305.00M | -310.00M | -599.00M | -221.00M | -314.00M | -212.00M | -573.00M | -596.00M |
| Share Repurchases | -552.00M | -212.00M | 0 | -657.00M | -375.00M | -1.15B | -200.00M | 0 | 0 | -229.00M | -144.00M | -490.00M |
| Debt Issued | 650.00M | 2.48B | 0 | 2.00B | 1.99B | 0 | 0 | 0 | 0 | 2.75B | 0 | — |
| Financing Cash Flow | -433.00M | 535.00M | -572.00M | 145.00M | -258.00M | -375.00M | -137.00M | -260.00M | -106.00M | -420.00M | -144.00M | 95.00M |
| Net Change in Cash | -33.00M | 166.00M | -225.00M | 299.00M | 38.00M | 130.00M | 27.00M | 101.00M | 68.00M | 152.00M | -158.00M | -112.00M |
| Free Cash Flow | 491.00M | 561.00M | 772.00M | 292.00M | 426.00M | 721.00M | 571.00M | 445.00M | 377.00M | 568.00M | 437.00M | 242.00M |
This table shows 12 quarterly periods of IQVIA's cash flow statement, from Q1 2026 back to Q2 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow IQV's reporting calendar. What is a cash flow statement?